Best Buy (BBY) PT Raised to $157 at BofA Securities

Best Buy (BBY) Declares $0.70 Quarterly Dividend; 2.3% Yield

Best Buy (NYSE: BBY) declared a quarterly dividend of $0.70 per share, or $2.8 annualized.

The dividend will be payable on October 5, 2021, to stockholders of record on September 14, 2021, with an ex-dividend date of September 13, 2021.

The annual yield on the dividend is 2.3... More

Best Buy (BBY) PT Raised to $130 at UBS

UBS analyst Michael Lasser raised the price target on Best Buy (NYSE: BBY) to $130.00 (from $127.00) while maintaining a Neutral rating.... More

Best Buy (BBY) PT Raised to $145 at Jefferies

Jefferies analyst Randal Konik raised the price target on Best Buy (NYSE: BBY) to $145.00 (from $136.00) while maintaining a Buy rating following earnings.

The analyst commented, "Implied 2H guidance exiting 1Q looked conservative to us, and recent momentum has management warming up to a... More

Best Buy (BBY) PT Raised to $140 at Guggenheim

Guggenheim analyst Steven Forbes raised the price target on Best Buy (NYSE: BBY) to $140.00 (from $135.00) while maintaining a Buy rating following reuslts.

The analyst commented, "Not only was product availability essentially a non-issue to growth during the 2Q but management meaningfully... More

Best Buy (BBY) PT Raised to $115 at Citi

Citi analyst Steven Zaccone raised the price target on Best Buy (NYSE: BBY) to $115.00 (from $109.00) while maintaining a Sell rating.... More

Best Buy (BBY) PT Raised to $146 at Piper Sandler

Piper Sandler analyst Peter Keith raised the price target on Best Buy (NYSE: BBY) to $146.00 (from $144.00) while maintaining an Overweight rating following earnings.

Pre-Open Stock Movers 08/24: (CARA) (PANW) (CWH) Higher; (TBPH) (MCW) (VSCO) Lower (more...)

Pre-Open Stock Movers:

Cara Therapeutics (Nasdaq: CARA) 27% HIGHER; Cara Therapeutics and Vifor Pharma today announced that the U.S. Food and Drug Administration (FDA) has approved KORSUVA (difelikefalin) for injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis .

Theravance Biopharma, Inc. (NASDAQ: TBPH) 22% LOWER; Announced top-line results from its Phase 2b dose-finding induction study of izencitinib, an orally administered, gut-selective pan-Janus kinase... More

Best Buy sees resilient work-from-home demand, raises sales forecast

By Uday Sampath Kumar

(Reuters) -Best Buy Co Inc said on Tuesday strong sales of home theater systems and work-from-home computer equipment despite market fears of pandemic-fueled growth shrinking prompted it to raise its annual comparable sales forecast, sending its shares up 5%.

The consumer electronics retailer's sales spiked last year when Americans, restricted by stay-at-home orders due to the COVID-19 pandemic, raced to buy laptops and other computer accessories for their home offices... More

Best Buy (BBY) Tops Q2 EPS by $1.13, Updates Guidance

Best Buy (NYSE: BBY) reported Q2 EPS of $2.98, $1.13 better than the analyst estimate of $1.85. Revenue for the quarter came in at $11.85 million versus the consensus estimate of $11.49 million.

GUIDANCE:

Best Buy sees Q3 2021 revenue of $11.4-11.6 billion, versus the consensus of $10.55... More